Triple Therapy for Cystic Fibrosis with a Phe508del CFTR Mutation. Reply

N Engl J Med. 2020 Feb 13;382(7):684. doi: 10.1056/NEJMc1916747.

Authors

Raksha Jain¹, Peter G Middleton², Steven M Rowe³

Affiliations

¹ University of Texas Southwestern Medical Center, Dallas, TX raksha.jain@utsouthwestern.edu.
² Westmead Hospital and CF Research Group, Westmead, NSW, Australia.
³ University of Alabama at Birmingham, Birmingham, AL.

PMID: 32053311
DOI: 10.1056/NEJMc1916747

No abstract available

Publication types

Letter
Comment

MeSH terms

Aminophenols
Chloride Channel Agonists
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
Cystic Fibrosis*
Humans
Mutation

Substances

Aminophenols
Chloride Channel Agonists
Cystic Fibrosis Transmembrane Conductance Regulator